PRCT - PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript
2024-05-01 12:56:10 ET
PROCEPT BioRobotics Corporation (PRCT)
Q1 2024 Earnings Conference Call
May 1, 2024 09:00 AM ET
Company Participants
Matt Basco - Vice President, Investor Relations
Reza Zadno - Chief Executive Officer
Sham Shiblaq - Chief Commercial Officer
Kevin Waters - Chief Financial Officer
Conference Call Participants
Craig Bijou - Bank of America
Matthew O'Brien - Piper Sandler
Josh Jennings - TD Cowen
Richard Newitter - Truist.
Brandon Vasquez - William Blair
Chris Pasquale - Nephron Research
Nathan Treybeck - Wells Fargo
Ryan Zimmerman - BTIG
Mike Kratky - Leerink Partners
Presentation
Operator
Good morning and welcome to PROCEPT BioRobotics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen only mode. We'll be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Matt Basco, Vice President, Investor Relations for a few introductory comments.
Matt Basco
Good morning and thank you for joining PROCEPT BioRobotics first quarter 2024 earnings conference call. Presenting on today's call are Reza Zadno, Chief Executive Officer, Sham Shiblaq, Chief Commercial Officer, and Kevin Waters, Chief Financial Officer.
Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance or forward-looking statements is defined under the Private Securities Litigation Reform Act of 1995. While these forward-looking statements are based on management's current expectations and beliefs, these statements are subject to several risks, uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call.
These risks and uncertainties are disclosed in more detail in PROCEPT BioRobotics filings with the Securities and Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned not to place under reliance on these forward-looking statements, which speak only as of today's date, May 1st, 2024, except as required by law PROCEPT BioRobotics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances or unanticipated events that may arise.
During the call, we also reference certain financial measures that are not prepared in accordance with GAAP. More information about how we use these non-GAAP financial measures as well as reconciliations of these measures to their nearest GAAP equivalent are included in our earnings release. With that, I'll turn the call over to Reza....
PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript